Boston Scientific BSX has been gaining from product launches and accretive acquisitions. International expansion remains a ...

Bullish option flow detected in Boston Scientific (BSX) with 2,458 calls trading, 1.0x expected, and implied vol increasing almost 2 points to ...

Boston Scientific (BSX) closed the latest trading day at $102.67, indicating a +1.97% change from the previous session's end. The stock outpaced the S&P 500's daily gain of 1.77%. On the other hand, ...

Boston Scientific Corp. closed 4.20% short of its 52-week high of $107.17, which the company achieved on February 5th.

National Science Day was first celebrated in 1987, and since then, it has become a key event that fosters the spirit of scientific inquiry and innovation in India. This year’s theme, “Empowering ...

Medical device giant Boston Scientific has announced that it has signed a definitive agreement to acquire Israeli medical device company SoniVie for an immediate payment of $360 million as well as ...

Credit: PeopleImages.com – Yuri A / Shutterstock. Boston Scientific is acquiring SoniVie, the developer of the catheter-based Tivus intravascular ultrasound system. With a current equity stake of ...

Ajax Health announced today that, with Boston Scientific and KKR, it formed a new medical technology entity called FlowMod. The new organization comes as a result of a collaboration between the ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. The acquisition sets up ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a strategic investor in SoniVie, Boston Scientific currently holds an equity ...

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that has developed the Tivus Intravascular Ultrasound System.